🔎 Trials Near Me

Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › Kansas › Overland Park

Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Overland Park, KS keessatti

Qorannoo 16 Kansara Qara'a Non-Small Cell f Overland Park fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Leawood · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06868277

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Namoota walitti qabaa jiraSadarkaa 2
  • University of Kansas Cancer Center, Fairway · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06667076

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Namoota walitti qabaa jiraSadarkaa 3
  • Saint Luke's South Hospital, Overland Park
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06758401

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Namoota walitti qabaa jiraSadarkaa 2/3
  • MidAmerica Cancer Care - Research, Merriam · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT04613596

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Namoota walitti qabaa jiraSadarkaa 3
  • University of Kansas Cancer Center-Overland Park, Overland Park
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT06500481

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • The University of Kansas Cancer Center - Indian Creek Campus, Overland Park
  • The University of Kansas Cancer Center, Investigational Drug Services, Fairway · Miili 3 fagaatti
  • The University of Kansas Clinical Research Center, Fairway · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT04389632

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • University of Kansas Clinical Research Center, Fairway · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • University of Kansas Clinical Research Center, Fairway · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2/3
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • University of Kansas Clinical Research Center, Fairway · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • University of Kansas Clinical Research Center, Fairway · Miili 3 fagaatti
18 Minutes · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT06031688

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • The University of Kansas Cancer Center, Fairway · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Bit-2026 · NCT06244771

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT06418204

Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC

Namoota walitti qabaa jiraSadarkaa 1/2
  • The University of Kansas Cancer Center (KUCC), Fairway · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ama-2026 · NCT04467723

A Study of IBI363 in Subjects with Advanced Solid Malignancies

Namoota walitti qabaa jiraSadarkaa 2
  • University of Kansas Medical Center (KUMC), Fairway · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Mud-2024 · NCT06281678

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

Namoota walitti qabaa jiraQorannoo ilaalaa
  • The University of Kansas Cancer Center (KUCC), Fairway · Miili 3 fagaatti
Umuriin 18 hanga 110 · Saalaa hunda · Haaromfame 23-Gur-2024 · NCT05332925

Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti

Qorannoo biroo Overland Park keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.